Your browser doesn't support javascript.
loading
Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects.
Bergström, Christel A S; Box, Karl; Holm, René; Matthews, Wayne; McAllister, Mark; Müllertz, Anette; Rades, Thomas; Schäfer, Kerstin J; Teleki, Alexandra.
Afiliação
  • Bergström CAS; Department of Pharmacy, Uppsala University, Uppsala Biomedical Center, P.O. Box 580, SE-75123 Uppsala, Sweden. Electronic address: christel.bergstrom@farmaci.uu.se.
  • Box K; pION Inc, Forest Row Business Park, Forest Row, East Sussex RH18 5DW, UK.
  • Holm R; Drug Product Development, Janssen R&D, Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Matthews W; Department of Product Development, GlaxoSmith Kline Medicines Research Centre, 2G118, Gunnels Wood Road, Stevenage, Herts, UK.
  • McAllister M; Drug Product Design, Pharmaceutical Sciences, Pfizer Ltd., Sandwich CT13 9NJ, Kent, UK.
  • Müllertz A; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
  • Rades T; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
  • Schäfer KJ; Pharmaceutical Development, Boehringer Ingelheim Pharma GmBH & Co KG, Birkendorfer strasse 65, 88397 Biberach an der Riss, Germany.
  • Teleki A; Department of Pharmacy, Uppsala University, Uppsala Biomedical Center, P.O. Box 580, SE-75123 Uppsala, Sweden.
Eur J Pharm Biopharm ; 139: 101-114, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30862481
ABSTRACT
Intrinsic dissolution rate (IDR) is the surface specific dissolution rate of a drug. In early drug development, this property (among other parameters) is measured in order to compare different polymorphs and salt forms, guide formulation decisions, and to provide a quality marker of the active pharmaceutical ingredient (API) during production. In this review, an update on different methods and small-scale techniques that have recently evolved for determination of IDR is provided. The importance of biorelevant media and the hydrodynamic conditions of dissolution are also discussed. Different preparation techniques for samples are presented with a focus on disc, particle- and crystal-based methods. A number of small-scale techniques are then described in detail, and their applicability domains are identified. Finally, an updated industrial perspective is provided about IDR's place in the early drug development process.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Composição de Medicamentos / Liberação Controlada de Fármacos / Desenvolvimento de Medicamentos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Composição de Medicamentos / Liberação Controlada de Fármacos / Desenvolvimento de Medicamentos Idioma: En Ano de publicação: 2019 Tipo de documento: Article